PMID- 32919655 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20210514 IS - 1873-0191 (Electronic) IS - 0928-4931 (Linking) VI - 117 DP - 2020 Dec TI - Injectable in situ forming thermo-responsive graphene based hydrogels for cancer chemo-photothermal therapy and NIR light-enhanced antibacterial applications. PG - 111294 LID - S0928-4931(20)33212-4 [pii] LID - 10.1016/j.msec.2020.111294 [doi] AB - Functionalized graphene oxide (GO) and reduced GO (rGO) based nanomaterials hold a great potential for cancer photothermal therapy. However, their systemic administration has been associated with an accelerated blood clearance and/or with suboptimal tumor uptake. To address these limitations, the local delivery of GO/rGO to the tumor site by 3D matrices arises as a promising strategy. In this work, injectable chitosan-agarose in situ forming thermo-responsive hydrogels incorporating GO (thermogel-GO) or rGO (thermogel-rGO) were prepared for the first time. The hydrogels displayed suitable injectability and gelation time, as well as good physicochemical properties and cytocompatibility. When irradiated with near infrared (NIR) light, the thermogel-rGO produced a 3.8-times higher temperature increase than thermogel-GO, thus decreasing breast cancer cells' viability to 60%. By incorporating an optimized molar ratio of the Doxorubicin:Ibuprofen combination on thermogel-rGO, this formulation mediated a chemo-photothermal effect that further diminished cancer cells' viability to 34%. In addition, the hydrogels' antibacterial activity was further enhanced upon NIR laser irradiation, which is an important feature considering the possible risk of infection at the site of administration. Overall, thermogel-rGO is a promising injectable in situ forming hydrogel for combinatorial chemo-photothermal therapy of breast cancer cells and NIR light enhanced antibacterial applications. CI - Copyright (c) 2020 Elsevier B.V. All rights reserved. FAU - Lima-Sousa, Rita AU - Lima-Sousa R AD - CICS-UBI - Centro de Investigacao em Ciencias da Saude, Universidade da Beira Interior, 6200-506 Covilha, Portugal. FAU - de Melo-Diogo, Duarte AU - de Melo-Diogo D AD - CICS-UBI - Centro de Investigacao em Ciencias da Saude, Universidade da Beira Interior, 6200-506 Covilha, Portugal. Electronic address: demelodiogo@fcsaude.ubi.pt. FAU - Alves, Catia G AU - Alves CG AD - CICS-UBI - Centro de Investigacao em Ciencias da Saude, Universidade da Beira Interior, 6200-506 Covilha, Portugal. FAU - Cabral, Catia S D AU - Cabral CSD AD - CICS-UBI - Centro de Investigacao em Ciencias da Saude, Universidade da Beira Interior, 6200-506 Covilha, Portugal. FAU - Miguel, Sonia P AU - Miguel SP AD - CICS-UBI - Centro de Investigacao em Ciencias da Saude, Universidade da Beira Interior, 6200-506 Covilha, Portugal; CPIRN-IPG - Centro de Potencial e Inovacao de Recursos Naturais, Instituto Politecnico da Guarda, 6300-559 Guarda, Portugal. FAU - Mendonca, Antonio G AU - Mendonca AG AD - CICS-UBI - Centro de Investigacao em Ciencias da Saude, Universidade da Beira Interior, 6200-506 Covilha, Portugal; Departamento de Quimica, Universidade da Beira Interior, 6201-001 Covilha, Portugal. FAU - Correia, Ilidio J AU - Correia IJ AD - CICS-UBI - Centro de Investigacao em Ciencias da Saude, Universidade da Beira Interior, 6200-506 Covilha, Portugal; CIEPQPF - Departamento de Engenharia Quimica, Universidade de Coimbra, 3030-790 Coimbra, Portugal. Electronic address: icorreia@ubi.pt. LA - eng PT - Journal Article DEP - 20200724 PL - Netherlands TA - Mater Sci Eng C Mater Biol Appl JT - Materials science & engineering. C, Materials for biological applications JID - 101484109 RN - 0 (Anti-Bacterial Agents) RN - 0 (Hydrogels) RN - 7782-42-5 (Graphite) SB - IM MH - Anti-Bacterial Agents/pharmacology MH - *Graphite MH - Hydrogels MH - *Neoplasms MH - Phototherapy MH - Photothermal Therapy OTO - NOTNLM OT - Antibacterial activity OT - Cancer OT - Chemo-photothermal therapy OT - Graphene family nanomaterials OT - Injectable hydrogel COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2020/09/14 06:00 MHDA- 2021/05/15 06:00 CRDT- 2020/09/13 20:26 PHST- 2020/02/21 00:00 [received] PHST- 2020/07/06 00:00 [revised] PHST- 2020/07/21 00:00 [accepted] PHST- 2020/09/13 20:26 [entrez] PHST- 2020/09/14 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] AID - S0928-4931(20)33212-4 [pii] AID - 10.1016/j.msec.2020.111294 [doi] PST - ppublish SO - Mater Sci Eng C Mater Biol Appl. 2020 Dec;117:111294. doi: 10.1016/j.msec.2020.111294. Epub 2020 Jul 24.